Chronic Kidney Disease (CKD) care is a significant cost driver for commercial insurance and Medicare, costing $124.5 billion for Medicare. Additionally, the cost of care exponentially increases with advancing stages of CKD. These costs can be avoided with better quality care and aligned physician incentives. Avalon’s Lab Values Management approach addresses three key drivers to improve outcomes while reducing costs.
